nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—Domperidone—ABCB1—adrenal gland cancer	0.0212	0.102	CrCbGaD
Prochlorperazine—Nefazodone—ABCB1—adrenal gland cancer	0.0176	0.0848	CrCbGaD
Prochlorperazine—Triflupromazine—ABCB1—adrenal gland cancer	0.0172	0.0826	CrCbGaD
Prochlorperazine—Aripiprazole—ABCB1—adrenal gland cancer	0.0164	0.0788	CrCbGaD
Prochlorperazine—Trazodone—ABCB1—adrenal gland cancer	0.0163	0.0785	CrCbGaD
Prochlorperazine—Clobazam—ABCB1—adrenal gland cancer	0.0153	0.0735	CrCbGaD
Prochlorperazine—Fluphenazine—ABCB1—adrenal gland cancer	0.0132	0.0635	CrCbGaD
Prochlorperazine—Clomipramine—ABCB1—adrenal gland cancer	0.0121	0.0581	CrCbGaD
Prochlorperazine—Chlorprothixene—ABCB1—adrenal gland cancer	0.012	0.0579	CrCbGaD
Prochlorperazine—Promethazine—ABCB1—adrenal gland cancer	0.0107	0.0515	CrCbGaD
Prochlorperazine—Trifluoperazine—ABCB1—adrenal gland cancer	0.0106	0.0508	CrCbGaD
Prochlorperazine—Quetiapine—ABCB1—adrenal gland cancer	0.0103	0.0493	CrCbGaD
Prochlorperazine—Desipramine—ABCB1—adrenal gland cancer	0.00973	0.0468	CrCbGaD
Prochlorperazine—Clozapine—ABCB1—adrenal gland cancer	0.00882	0.0424	CrCbGaD
Prochlorperazine—Chlorpromazine—ABCB1—adrenal gland cancer	0.0083	0.0399	CrCbGaD
Prochlorperazine—Imipramine—ABCB1—adrenal gland cancer	0.00825	0.0397	CrCbGaD
Prochlorperazine—HTR2C—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00678	0.00856	CbGpPWpGaD
Prochlorperazine—DRD3—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00637	0.00804	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00624	0.00788	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00615	0.00777	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00598	0.00756	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00588	0.00742	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00578	0.0073	CbGpPWpGaD
Prochlorperazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00566	0.00715	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00548	0.00692	CbGpPWpGaD
Prochlorperazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00539	0.00681	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00533	0.00674	CbGpPWpGaD
Prochlorperazine—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00527	0.00665	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00508	0.00641	CbGpPWpGaD
Prochlorperazine—DRD2—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00487	0.00616	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00475	0.006	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00471	0.00594	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00468	0.00592	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00462	0.00584	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00455	0.00574	CbGpPWpGaD
Prochlorperazine—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00447	0.00564	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00442	0.00558	CbGpPWpGaD
Prochlorperazine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00427	0.00539	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0042	0.0053	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00418	0.00527	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00412	0.0052	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00406	0.00513	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00405	0.00512	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00401	0.00507	CbGpPWpGaD
Prochlorperazine—DRD3—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00401	0.00507	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00383	0.00484	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—TSHR—adrenal gland cancer	0.00362	0.00457	CbGpPWpGaD
Prochlorperazine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00359	0.00454	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00358	0.00453	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00352	0.00444	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00348	0.00439	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00346	0.00437	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00338	0.00427	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00332	0.00419	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00327	0.00413	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	0.0032	0.00403	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00314	0.00396	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00309	0.0039	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00307	0.00388	CbGpPWpGaD
Prochlorperazine—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00307	0.00388	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00301	0.00381	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00297	0.00375	CbGpPWpGaD
Prochlorperazine—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00297	0.00374	CbGpPWpGaD
Prochlorperazine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00291	0.00368	CbGpPWpGaD
Prochlorperazine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00284	0.00359	CbGpPWpGaD
Prochlorperazine—DRD3—G alpha (i) signalling events—POMC—adrenal gland cancer	0.0027	0.00341	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00265	0.00334	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00243	0.00307	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0024	0.00304	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00237	0.00299	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00236	0.00298	CbGpPWpGaD
Prochlorperazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00235	0.00297	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0023	0.0029	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0022	0.00278	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00215	0.00271	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00214	0.00271	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—GNAS—adrenal gland cancer	0.00211	0.00266	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00208	0.00263	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00207	0.00262	CbGpPWpGaD
Prochlorperazine—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00207	0.00261	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—GNRHR—adrenal gland cancer	0.00206	0.0026	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00205	0.00258	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00203	0.00256	CbGpPWpGaD
Prochlorperazine—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.002	0.00252	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00199	0.00251	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00198	0.0025	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00196	0.00247	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00191	0.00241	CbGpPWpGaD
Prochlorperazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.0019	0.00241	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00186	0.00235	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00186	0.00235	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.00186	0.00235	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00184	0.00232	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00182	0.0023	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00181	0.00229	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00181	0.00228	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00181	0.00228	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0018	0.00227	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.0018	0.00227	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00178	0.00225	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00178	0.00224	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00177	0.00224	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00175	0.00221	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00174	0.0022	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00169	0.00213	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00166	0.00209	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00164	0.00208	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00164	0.00207	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—POMC—adrenal gland cancer	0.00164	0.00207	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00163	0.00206	CbGpPWpGaD
Prochlorperazine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00163	0.00205	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00161	0.00204	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00161	0.00203	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00159	0.002	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00159	0.002	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00158	0.002	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00156	0.00197	CbGpPWpGaD
Prochlorperazine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.00155	0.00195	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00154	0.00194	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00153	0.00193	CbGpPWpGaD
Prochlorperazine—DRD3—Circadian rythm related genes—TP53—adrenal gland cancer	0.00145	0.00183	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00144	0.00181	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00142	0.0018	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00142	0.00179	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—POMC—adrenal gland cancer	0.00142	0.00179	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.00138	0.00175	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00137	0.00173	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00133	0.00168	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—CDC42—adrenal gland cancer	0.0013	0.00165	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SPRY2—adrenal gland cancer	0.0013	0.00164	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TSHR—adrenal gland cancer	0.00127	0.0016	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	0.00125	0.00158	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00125	0.00157	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00125	0.00157	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00123	0.00156	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.00123	0.00156	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—POMC—adrenal gland cancer	0.00123	0.00155	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00121	0.00153	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MEN1—adrenal gland cancer	0.00119	0.0015	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00119	0.0015	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00118	0.00149	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00116	0.00146	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00114	0.00144	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.00113	0.00143	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.00113	0.00142	CbGpPWpGaD
Prochlorperazine—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	0.00111	0.0014	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0011	0.00139	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	0.0011	0.00139	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00109	0.00137	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.00108	0.00136	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00108	0.00136	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00107	0.00135	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00106	0.00134	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00105	0.00133	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00105	0.00133	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	0.00103	0.0013	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00103	0.0013	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00101	0.00128	CbGpPWpGaD
Prochlorperazine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.00101	0.00128	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000998	0.00126	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000994	0.00126	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00098	0.00124	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000976	0.00123	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	0.000969	0.00122	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000964	0.00122	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00096	0.00121	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000954	0.0012	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	0.000951	0.0012	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000936	0.00118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000936	0.00118	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000924	0.00117	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000921	0.00116	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	0.000911	0.00115	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000908	0.00115	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000905	0.00114	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	0.000894	0.00113	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000892	0.00113	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000892	0.00113	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.00088	0.00111	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—POMC—adrenal gland cancer	0.000839	0.00106	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000801	0.00101	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000788	0.000995	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	0.000771	0.000973	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	0.000743	0.000938	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	0.000736	0.00093	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000728	0.000919	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000718	0.000907	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000707	0.000893	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000695	0.000878	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000694	0.000877	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000683	0.000863	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000683	0.000862	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000672	0.000848	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000668	0.000844	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000665	0.000839	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000644	0.000813	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000642	0.000811	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000638	0.000806	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	0.000631	0.000796	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000623	0.000786	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.00062	0.000783	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TERT—adrenal gland cancer	0.000618	0.000781	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.00059	0.000745	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000583	0.000736	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000583	0.000736	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	0.000579	0.000731	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.00057	0.000719	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000568	0.000718	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000563	0.000712	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	0.000558	0.000705	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	0.000553	0.000699	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.00055	0.000694	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000549	0.000693	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000544	0.000687	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	0.00054	0.000681	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—BAD—adrenal gland cancer	0.000538	0.000679	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000536	0.000677	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000531	0.00067	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—POMC—adrenal gland cancer	0.000496	0.000626	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	0.00049	0.000618	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000485	0.000612	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000475	0.000599	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.000473	0.000597	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000466	0.000589	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	0.000464	0.000587	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000457	0.000577	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000435	0.000549	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.00043	0.000543	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000424	0.000536	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000412	0.00052	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000411	0.00052	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	0.000404	0.00051	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000398	0.000502	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000393	0.000496	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000386	0.000487	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	0.000379	0.000479	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	0.000375	0.000473	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	0.000372	0.00047	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	0.000368	0.000464	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000367	0.000463	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000363	0.000459	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000362	0.000457	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000357	0.00045	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000354	0.000447	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000351	0.000443	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000317	0.0004	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000307	0.000387	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	0.00028	0.000354	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000271	0.000342	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000266	0.000336	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000265	0.000334	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000262	0.00033	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000257	0.000325	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000252	0.000318	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	0.000243	0.000307	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TP53—adrenal gland cancer	0.000235	0.000297	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	0.000214	0.000271	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000211	0.000267	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	0.000211	0.000266	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000207	0.000262	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	0.000204	0.000258	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	0.00018	0.000227	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	0.000177	0.000223	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000174	0.00022	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000173	0.000219	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000138	0.000174	CbGpPWpGaD
